New Onset Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about New Onset clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction

Acute Myocardial InfarctionAtrial Fibrillation New Onset
Shanghai 10th People's Hospital774 enrolled5 locationsNCT04528511
Recruiting
Phase 1Phase 2

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

Type 1 DiabetesNew Onset
City of Hope Medical Center120 enrolled11 locationsNCT07061574
Recruiting
Phase 4

Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients

Critical IllnessNew Onset Atrial Fibrillation
Dr. Stephanie Sibley200 enrolled4 locationsNCT05829317
Recruiting
Phase 3

Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial

Atrial Fibrillation New Onset
Population Health Research Institute400 enrolled1 locationNCT05841056
Recruiting
Not Applicable

Effect of Left Posterior Pericardiotomy for the Prevention of POAF

Coronary Artery DiseaseAtrial Fibrillation New OnsetPericardial Effusion
Seoul National University Hospital270 enrolled1 locationNCT06159985
Recruiting

Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion

ThrombosisStrokeAtrial Fibrillation (AF)+4 more
Nedim Tojaga150 enrolled1 locationNCT06949319
Recruiting
Phase 2Phase 3

EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source

Embolic Stroke of Undetermined SourceAtrial Fibrillation New Onset
University of East Anglia100 enrolled1 locationNCT06715449
Recruiting

Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry

Aortic StenosisHeart BlockAtrial Fibrillation New Onset
Kansas City Heart Rhythm Research Foundation50 enrolled2 locationsNCT06055751
Recruiting

Tracking Atrial Fibrillation After Intensive Care Admission

Atrial FibrillationAtrial Fibrillation New OnsetNew Onset Atrial Fibrillation
University of Oxford100 enrolled1 locationNCT05229211
Recruiting
Phase 3

Nifekalant Versus Amiodarone in New-Onset Atrial Fibrillation After Cardiac Surgery

New Onset Atrial FibrillationComplications; Cardiac, Postoperative
Beijing Anzhen Hospital274 enrolled1 locationNCT05169866
Recruiting
Not Applicable

STROKESTOP III - Optimized Method for Atrial Fibrillation Screening

Atrial FibrillationAtrial Fibrillation New Onset
Danderyd Hospital2,200 enrolled2 locationsNCT06275503
Recruiting
Phase 3

MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care

Atrial Fibrillation New Onset
Sunnybrook Health Sciences Centre200 enrolled5 locationsNCT05287191